STEP 11 / 14

期刊選擇與投稿策略

投高、投對、投快——三者只能選二。如何用 scope/IF/受眾/OA 四維度做戰略選擇,並避開掠奪性期刊陷阱。

Aim high, aim right, aim fast — pick two. Use scope/IF/audience/OA to choose strategically, and dodge predatory journals.

投稿是策略遊戲

許多人投稿失敗不是因為論文不好,而是因為投錯期刊。錯誤的期刊會在 24 小時內 desk-reject (editor 一看就知道不適合),浪費你 3-6 個月找下一家。

正確策略:在寫之前就鎖定 1 個 first-choice + 2 個 backup,並照那家期刊的 author guidelines 寫。等寫完才挑期刊,注定要返工。

Many submissions fail not because of poor writing but because of poor journal fit. Wrong journal = desk-reject in 24 hours, costing 3-6 months looking for the next.

Correct strategy: lock in 1 first-choice + 2 backups before writing, and follow that journal's author guidelines. Picking a journal after writing means rework.

💡
Pre-submission inquiry:對 high-IF 期刊 (Nature, Cell, Lancet 等),可在投稿前發 1 段 email 摘要到 editorial office 詢問 fit。Editor 通常 1-2 週內回覆「encourage to submit / not a good fit」,能避免你白寫一個版本的 cover letter。 Pre-submission inquiry: for high-IF journals (Nature, Cell, Lancet), email a 1-paragraph summary to the editorial office before submitting. Editors typically reply within 1-2 weeks with "encourage to submit / not a good fit" — saves a wasted submission cycle.

一、四維評估

維度檢查方法紅燈
Scope (主題範圍) 讀官網 "Aims & Scope" + 近 6 個月 5-10 篇文章類型Read "Aims & Scope" + 5-10 articles from the last 6 months 主題與你完全不重疊Zero topical overlap
Audience (受眾) 看誰被引用、誰寫 editorialWho gets cited; who writes editorials 你想被臨床醫師看到,但期刊讀者全是 basic scientistYou want clinicians to read it; readers are all basic scientists
IF / CiteScore / SNIP / SJR JCR、Scopus、Scimago Journal RankJCR, Scopus, Scimago Journal Rank IF 突然暴跌 (可能 Clarivate 警告)IF sudden drop (Clarivate warning)
OA Model Gold (作者付 APC)、Hybrid、Green (preprint OK)、Diamond (免費)Gold (APC), Hybrid, Green (preprint OK), Diamond (free) funder 強制 OA 但你選了 paywall 期刊Funder mandates OA but you picked paywall
Time-to-decision SciRev.org、期刊官網「median time to first decision」SciRev.org or journal's "median time to first decision" 論文 deadline 緊但期刊 median 4 個月Tight deadline but median 4 months
Acceptance rate 期刊 transparency reportJournal transparency report <5% 接受率對首投來說太冒險<5% acceptance is risky for a first try
APC 費用 官網 author fees 頁Journal author-fees page $3500+ APC 但 lab 沒預算$3500+ APC but no lab budget

二、Open Access 四模式

🥇 Gold OA

作者付 APC ($1500-$11000),論文立即免費公開。例:PLOS ONE, Nature Communications, BMC, Scientific Reports。NIH/Wellcome funder 偏好。

Author pays APC ($1500-$11000), paper immediately open. E.g., PLOS ONE, Nature Communications, BMC, Scientific Reports. Preferred by NIH/Wellcome.

🟢 Green OA

傳統 paywall 但允許作者把 accepted manuscript 自存到 institutional repository / bioRxiv / PubMed Central(通常 6-12 月 embargo)。

Traditional paywall but author can self-archive the accepted manuscript to institutional repository / bioRxiv / PubMed Central (often 6-12 month embargo).

🟡 Hybrid OA

傳統訂閱期刊 + 「付費可選 OA」($2000-$5000)。被 cOAlition S 與 Plan S 視為「double-dipping」而排斥。

Subscription journal + "optional pay-for-OA" ($2000-$5000). Considered "double-dipping" by cOAlition S / Plan S.

💎 Diamond OA

免費投稿、免費讀。由學會、機構、聯盟資助。例:eLife (post-2023), Wellcome Open Research, F1000Research。對 LMIC 作者特別友善。

Free to publish, free to read. Funded by societies / institutions / consortia. E.g., eLife (post-2023), Wellcome Open Research, F1000Research. Especially friendly to LMIC authors.

三、避開掠奪性期刊

掠奪性期刊 (predatory journals) 收費快、審查空轉、學術記錄無保障。投了不只浪費 APC,還會被嚴肅期刊視為 "predatory record" 而拒收後續投稿。

2026 年驗證工具:Cabells Predatory Reports (付費精準) + Think.Check.Submit. (免費 checklist) + DOAJ (Directory of Open Access Journals 白名單)。

Predatory journals collect fees fast, run sham peer review, and offer no archival guarantees. Submitting wastes APC and creates a "predatory record" that mainstream journals reject in future.

2026 verification: Cabells Predatory Reports (paid, precise), Think.Check.Submit. (free checklist), DOAJ (Directory of Open Access Journals — whitelist).

🚩 主動邀稿、語氣浮誇

"Esteemed Researcher, We are highly impressed by your work..." — 真期刊不會主動寄這種信。

"Esteemed Researcher, We are highly impressed by your work..." — real journals don't cold-email like this.

🚩 7 天就能完成 peer review

正常 peer review 至少 4-12 週。承諾「rapid 7 天」幾乎一定是空轉。

Real peer review takes 4-12 weeks. "Rapid 7 days" is a near-certain sham.

🚩 編輯團隊不透明

沒列 editor 全名 / 機構,或列了但對方否認 (常被冒用)。Google 一下 editor 的姓名 + 期刊名。

No editor names/affiliations listed, or listed people deny involvement (often impersonated). Google editor name + journal name.

🚩 網站不專業

排版亂、圖片低解析、英文文法錯多、模仿大期刊命名 ("Lancet of XXX")。

Sloppy layout, low-res images, broken English, big-journal-mimicking name ("Lancet of XXX").

🚩 不在 PubMed/Scopus/DOAJ

真期刊一定被至少一個主要 indexing service 收錄。OA 期刊未在 DOAJ → 100% 警示。

Real journals appear in at least one major index. OA journal not in DOAJ → 100% red flag.

🚩 假 IF / 自製 metric

"Universal Impact Factor 8.5" — Clarivate 才發 IF。任何不是 JCR 的「IF」都是假的。

"Universal Impact Factor 8.5" — only Clarivate issues IF. Any non-JCR "IF" is fake.

四、Cover Letter 範本

模板無亮點

「Dear Editor, Please find enclosed our manuscript entitled '...'. We hope it will be considered for publication in your esteemed journal. Sincerely, ...」

"Dear Editor, Please find enclosed our manuscript entitled '...'. We hope it will be considered for publication in your esteemed journal. Sincerely, ..."

說服 editor

「Dear Dr. [Editor name], We are pleased to submit our manuscript '[Title]' for consideration as an Original Research Article in [Journal].

Our study addresses [gap] by [approach], identifying [main finding with 1 number]. We believe this is a strong fit for [Journal] because [link to readership / recent special issue / cited recent paper].

The work has not been published elsewhere, all authors approve submission, and there are no competing interests. Suggested reviewers: Dr. X (institution; expertise), Dr. Y (...). Excluded reviewers: Dr. Z (direct competitor).

Sincerely, [Name, ORCID, affiliation]

"Dear Dr. [Editor name], We are pleased to submit '[Title]' as an Original Research Article in [Journal].

Our study addresses [gap] by [approach], identifying [main finding with one number]. We believe this is a strong fit for [Journal] because [link to readership / recent special issue / cited recent paper].

The work has not been published elsewhere; all authors approve submission; no competing interests. Suggested reviewers: Dr. X (institution, expertise); Dr. Y. Excluded reviewers: Dr. Z (direct competitor).

Sincerely, [Name, ORCID, affiliation]"

五、期刊選擇決策樹

🌳 產出 Top-3 期刊清單

Q1:
研究是否「具備跨領域突破性」(real Cell/Nature/Science material)?→ 是 → 1st choice 投 top-tier (CNS, NEJM, Lancet);2nd 投 specialty top (Nat Med, Cell Rep Med); 3rd 投 specialty mid (Genome Biol, EBioMedicine)。
Q2:
研究是「方法學突破」?→ 是 → Nat Methods, Genome Biol, Bioinformatics, Nat Comput Sci。
Q3:
是否為「高品質但 incremental」?→ 是 → specialty solid (Cancer Res, Cell Death Dis, Sci Rep)。Top-tier 浪費時間。
Q4:
需要 OA 但 APC 預算有限?→ 是 → Diamond OA (Wellcome Open Research, F1000Research, eLife)。
Q5:
有受眾選擇權?→ 臨床受眾 → JAMA, NEJM, BMJ, Lancet 系列;→ 基礎研究 → Cell, Nature, Cell Rep, Genome Biol。
Q6:
三個候選期刊都通過 Think.Check.Submit. 嗎?→ 否 → 不通過的剃掉。
Q1:
Is the work cross-field, breakthrough quality (real CNS material)? → Yes → 1st: top-tier (CNS, NEJM, Lancet); 2nd: specialty top (Nat Med, Cell Rep Med); 3rd: specialty mid (Genome Biol, EBioMedicine).
Q2:
Methods breakthrough? → Yes → Nat Methods, Genome Biol, Bioinformatics, Nat Comput Sci.
Q3:
High-quality but incremental? → Yes → specialty solid (Cancer Res, Cell Death Dis, Sci Rep). Top-tier wastes time.
Q4:
Need OA but limited APC budget? → Yes → Diamond OA (Wellcome Open Research, F1000Research, eLife).
Q5:
Audience preference? Clinical → JAMA, NEJM, BMJ, Lancet family; Basic → Cell, Nature, Cell Rep, Genome Biol.
Q6:
All three pass Think.Check.Submit.? → No → remove failures.

📝 自我檢測

1. 哪個是「掠奪性期刊」最可靠的紅旗?

1. Most reliable red flag of a predatory journal?

A. 期刊網站使用 .org 結尾A. Website ends in .org
B. 期刊收 APCB. Journal charges an APC
C. 承諾 7 天內完成 peer review、列出假 "Universal Impact Factor"C. Promises 7-day peer review and lists a fake "Universal Impact Factor"
D. 是 OA 期刊D. It's an OA journal

2. 你做的是 incremental 但紮實的 cohort 研究 (n=240),最佳投稿策略是?

2. Your study is solid but incremental (cohort n=240). Best strategy?

A. 從 specialty solid 期刊開始 (Cancer Res, Sci Rep),避開 CNS 浪費時間A. Start at specialty-solid (Cancer Res, Sci Rep); skip CNS to save time
B. 直接投 Nature, Cell, Science 試試運氣B. Try Nature/Cell/Science for luck
C. 同時投 5 家期刊增加機會C. Submit to 5 journals simultaneously
D. 只投 IF > 30 的D. Only submit to IF > 30

3. NIH funder 強制 OA。下列哪個 OA 模式 funder 不接受?

3. NIH mandates OA. Which OA model is generally not accepted?

A. Gold OAA. Gold OA
B. Hybrid (paywall + 付 OA),被視為 double-dippingB. Hybrid (paywall + paid OA), considered double-dipping
C. Diamond OAC. Diamond OA
D. Green OA (preprint + PMC deposit)D. Green OA (preprint + PMC deposit)